Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_3
1
20%
Ph phase_1
2
40%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (40.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)

Trials by Status

not_yet_recruiting120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_2

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

NCT07250594
completedphase_1

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

NCT04088721
completedphase_3

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

NCT02624947
completedphase_1

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

NCT03880058
completedphase_2

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

NCT00888446

Clinical Trials (5)

Showing 5 of 5 trials
NCT07250594Phase 2

A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma

Not Yet Recruiting
NCT04088721Phase 1

Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis

Completed
NCT02624947Phase 3

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Completed
NCT03880058Phase 1

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

Completed
NCT00888446Phase 2

Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5